M. Davis

Genetics · 2016

A researcher in the Science corpus: 1 paper; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom M. Davis trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Q. Ostrom
  2. L. Morgan

Papers from M. Davis's perspective

Ordered by how strongly the researchers M. Davis trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. (New England Journal of Medicine)
  2. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. (Journal of Neurosurgery)
  3. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. (The Lancet Oncology)
  4. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. (The Lancet Oncology)
  5. An integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR and NF1 (Cancer Cell)
  6. NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality. (European Journal of Cancer)
  7. The Somatic Genomic Landscape of Glioblastoma (Cell)
  8. Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial. (Journal of the American Medical Association (JAMA))
  9. CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012 (Neuro-Oncology)
  10. Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors (Neurology)

Their papers